Quantcast
Investor's Business Daily investors.com 10 Nov, 2023 21:45 am

Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade

Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade
Amphastar Pharmaceuticals stock saw its IBD SmartSelect Composite Rating rise to 98 Friday, up from 93 the day before.
Read full story at investors.com